Foreign-made hyperlipemia medicines showed sustained growth of the sector’s domestic sales in February, an industry report showed recently.
According to Shinhan Investment Corp., Pfizer’s Lipitor and AstraZeneca’s Crestor showed a double-digit growth in February sales, reaching 11.7 percent and 22 percent, respectively, over the previous month.
The two companies plans to emphasize the su...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.